Tsai-Wang Chang

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

José Baselga, Ian Bradbury, Holger Eidtmann et al. · The Lancet · 2012 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +14

RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy

Debora Fumagalli, David Venet, Michail Ignatiadis et al. · JAMA Oncology · 2016 · 157 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Current Trends in and Indications for Endoscopy-Assisted Breast Surgery for Breast Cancer: Results from a Six-Year Study Conducted by the Taiwan Endoscopic Breast Surgery Cooperative Group

Hung-Wen Lai, Shou-Tung Chen, Dar‐Ren Chen et al. · PLoS ONE · 2016 · 94 citations · Full text

Medicine, Oncology, Surgery +10

The prognostic significance of metaplastic carcinoma of the breast (MCB) – A case controlled comparison study with infiltrating ductal carcinoma

Hung-Wen Lai, Ling‐Ming Tseng, Tsai-Wang Chang et al. · The Breast · 2013 · 88 citations

Medicine, Oncology, Surgery +15

Glutathione S-transferase polymorphisms associated with risk of breast cancer in southern Taiwan

Tsai-Wang Chang, Shuei-Ming Wang, Yue Leon Guo et al. · The Breast · 2006 · 50 citations

Life Sciences, Genetics, Molecular Genetics +14